Parkinson Disease

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson Disease Trial in United States (Personal KinetiGraph™ (PKG™))

Active, not recruiting
  • Parkinson Disease
  • Personal KinetiGraph™ (PKG™)
  • Sacramento, California
  • +11 more
Mar 3, 2020

Excessive Sleepiness, Parkinson Disease Trial in United States (JZP-110, Placebo)

Completed
  • Excessive Sleepiness
  • Parkinson Disease
  • Los Angeles, California
  • +24 more
Jan 3, 2020

Parkinson Disease Trial in Worldwide (Ropinirole)

Completed
  • Parkinson Disease
  • Birmingham, Alabama
  • +75 more
Mar 21, 2017

Parkinson Disease, Parkinson's Disease Trial in Worldwide (Ropinirole XL (formerly CR))

Completed
  • Parkinson Disease
  • Parkinson's Disease
  • Ropinirole XL (formerly CR)
  • Birmingham, Alabama
  • +74 more
Mar 21, 2017

Parkinson Disease Trial in United States (Virtual Visits)

Completed
  • Parkinson Disease
  • Virtual Visits
  • San Francisco, California
  • +19 more
Dec 1, 2016

Parkinson's Disease, Parkinson Disease, Dyskinesias Trial in United States (ropinirole controlled-release (REQUIP CR) for RLS)

Completed
  • Parkinson's Disease
  • +2 more
  • ropinirole controlled-release (REQUIP CR) for RLS
  • Anniston, Alabama
  • +69 more
Jan 16, 2017

Parkinson Disease Trial in Germany, Spain, United States (Spheramine (BAY86-5280), Placebo)

Terminated
  • Parkinson Disease
  • Spheramine (BAY86-5280)
  • Placebo
  • Birmingham, Alabama
  • +14 more
Sep 23, 2015

Parkinson Disease Trial in Worldwide (Placebo, Pramipexole)

Completed
  • Parkinson Disease
  • Sun City, Arizona
  • +118 more
Jun 3, 2014

PROGENI Family Study of LRRK2

Completed
  • Parkinson Disease
    • Weston, Florida
    • +9 more
    Dec 13, 2013

    Impulse Control Disorders in Parkinson's Patients Treated With

    Completed
    • Parkinson Disease
      • Gilbert, Arizona
      • +48 more
      Nov 11, 2013

      Parkinson Disease Trial in Canada, United States (NS 2330)

      Completed
      • Parkinson Disease
      • NS 2330
      • Peoria, Arizona
      • +54 more
      Oct 28, 2013

      Parkinson Disease Trial in United States (Ropinirole XL (formerly CR))

      Completed
      • Parkinson Disease
      • Ropinirole XL (formerly CR)
      • Scottsdale, Arizona
      • +9 more
      May 2, 2013

      Parkinson Disease Trial in Canada, United States (Coenzyme Q10 with vitamin E, with vitamin E)

      Terminated
      • Parkinson Disease
      • Coenzyme Q10 with vitamin E
      • placebo with vitamin E
      • Birmingham, Alabama
      • +67 more
      Dec 24, 2012

      Parkinson Disease Trial in Kansas City (Requip PR, Mirapex)

      Completed
      • Parkinson Disease
      • Kansas City, Kansas
        University of Kansas Medical Center
      Jul 21, 2012

      Parkinson Disease Trial in Canada, Puerto Rico, United States (CEP-1347 10mg, CEP1347 25mg, CEP-1347 50mg)

      Terminated
      • Parkinson Disease
      • CEP-1347 10mg
      • +3 more
      • Phoenix, Arizona
      • +65 more
      May 8, 2012

      Parkinson's Research: The Organized Genetics Initiative

      Completed
      • Parkinson Disease
        • Phoenix, Arizona
        • +57 more
        Feb 15, 2011

        PRECEPT Study Cohort

        Unknown status
        • Parkinson Disease
          • Phoenix, Arizona
          • +54 more
          Mar 26, 2008

          Parkinson Disease Trial in Worldwide (sumanirole)

          Terminated
          • Parkinson Disease
          • Birmingham, Alabama
          • +109 more
          Jan 17, 2007

          Parkinson Disease Trial in Worldwide (sumanirole, ropinirole)

          Completed
          • Parkinson Disease
          • Hot Springs, Arkansas
          • +101 more
          Jun 6, 2006

          Parkinson Disease Trial in Worldwide (sumanirole)

          Completed
          • Parkinson Disease
          • Birmingham, Alabama
          • +134 more
          Jun 6, 2006